Back to Department of Urology
Urology Patient Care
Setting the Standard
Our department works to relieve urologic disease and disability by delivering world-class treatment that integrates the latest innovations.
About Us
We have an expansive clinical presence, in both the University of Michigan Health and in clinics across the Midwest. Our clinical practices have been ranked as one of the best in the country, consistently praised by U.S. News and World Reports. Additionally, numerous Urology faculty members have received national recognitions for their contributions to the field.
Our Care
We have been providing care for urologic conditions since 1920, and are the leading regional referral center for complex urologic surgery.
Featured News & Stories
Medical School News
Regents approve Urology acting chairs, Cell and Developmental Biology interim chair
The Board of Regents on Oct. 15 approved the appointments of two acting chairs and one interim chair in the Medical School. Effective Sept. 18, Brent K. Hollenbeck, M.D. M.S., is acting chair of the Department of Urology through Feb. 28, 2027. Effective March 1, 2027, Todd M. Morgan, M.D., will assume the role of acting chair. Billy Tsai, Ph.D., is interim chair of the Department of Cell and Developmental Biology, effective Sept. 9.
Health Lab
Comprehensive DNA sequencing reveals hidden drivers of cancer
Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
Department News
Michigan Medicine Urology Earns Coloplast Titan Center of Excellence Designation
Dr. Bahaa Malaeb and Michigan Medicine Urology receive Coloplast's Titan Center of Excellence designation for excellence in prosthetic urology care.
Health Lab
Prostate cancer and hereditary risk: A doctor explains the connection
Some genetic mutations linked to breast cancer also can affect men, but in a different way. A Michigan Medicine urologist explains the connection.
Department News
U-M Awards Strategic Initiative Fund Grant to Diabetes Reprogramming Initiative Led by Dr. Ganesh Palapattu
Dr. Ganesh Palapattu's Michigan Initiative to Reprogram Cells for Diabetes (MIRC-D) has been selected for funding through the University of Michigan's Strategic Initiative Fund, supporting innovative, multidisciplinary research aimed at transforming diabetes treatment.
Department News
Medical School Honors Three Faculty Members with Endowed Professorships
The University of Michigan Medical School celebrates Dr. Salami, Dr. Kraft and Dr. Gupta on receiving endowed professorships, one of the institution’s highest faculty honors.
